Cross-fund · 3 holders
GANX
GAIN THERAPEUTICS INC
CUSIP 36269B105
3
Tracked holders
$2.4M
Aggregate value
865,747
Shares
5
Active funds
Funds holding GANX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $1.8M | — | +35,549 | +6.7% |
| BlackRock | Institutional | Q1 2026 | $436,589 | — | +15,467 | +7.4% |
| Citadel | Multi-Strategy | Q1 2026 | $137,352 | — | −6,700 | −8.6% |
| Millennium | Multi-Strategy | Q1 2026 | — | — | −14,002 | EXITED |
| Point72FEAT | Multi-Strategy | Q1 2026 | — | — | −32,480 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.